Neonatal encephalopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in methyl-CpG-binding protein 2 (MECP2) in males can lead to various phenotypes, ranging from neonatal encephalopathy to intellectual disability.
|
31536832 |
2020 |
Neonatal encephalopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We report a case of MECP2 mutation in a male patient who exhibited neonatal encephalopathy.
|
29631775 |
2018 |
Neonatal encephalopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A rare MeCP2_e1 mutation first described in a male patient with severe neonatal encephalopathy.
|
27090848 |
2016 |
Neonatal encephalopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Although it was initially thought that MECP2 pathogenic mutations in males were not compatible with life, starting from 1999 about 60 male patients have been identified and their phenotype varies from severe neonatal encephalopathy to mild intellectual disability.
|
26490184 |
2016 |
Neonatal encephalopathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Methyl-CpG binding protein 2 gene (MECP2) testing is indicated for patients with numerous clinical presentations, including Rett syndrome (classic and atypical), unexplained neonatal encephalopathy, Angelman syndrome, nonspecific mental retardation, autism (females), and an X-linked family history of developmental delay.
|
22123427 |
2012 |
Neonatal encephalopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In this study we present a new clinical association of severe neonatal encephalopathy (Lubs syndrome) and HSCR, in a male patient carrying a duplication at the Xq28 region which encompasses the MECP2 and L1CAM genes.
|
20860806 |
2010 |
Neonatal encephalopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Males with MECP2 mutations present with a broad spectrum of phenotypes ranging from neonatal encephalopathy to nonsyndromic mental retardation (MR).
|
20098342 |
2010 |
Neonatal encephalopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In this study, DNA samples from individuals with schizophrenia and other psychiatric diseases were scanned in order to explore whether the phenotypic spectrum of mutations in the MECP2 gene can extend beyond the traditional diagnoses of RTT in females and severe neonatal encephalopathy in males.
|
15211631 |
2004 |
Neonatal encephalopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Neonatal encephalopathy in males is part of a spectrum of disorders caused by MECP2 dysfunction.
|
12719401 |
2003 |
Neonatal encephalopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the MECP2 gene are involved in a broad spectrum of phenotypes from classical Rett syndrome to mild intellectual difficulties in females and neonatal encephalopathy in males.
|
14529314 |
2003 |
Neonatal encephalopathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
We conclude that MECP2 screening should be considered in males with severe neonatal encephalopathy and in males and females with a bilateral polymicrogyria syndrome.
|
11930274 |
2002 |
Neonatal encephalopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
MECP2 mutations have subsequently been identified in patients with a variety of clinical syndromes ranging from mild learning disability in females to severe mental retardation, seizures, ataxia, and sometimes neonatal encephalopathy in males.
|
11262731 |
2001 |
Neonatal encephalopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The unmitigated impact of mutant MECP2 can be inferred from the few males who have been born into RTT kindreds with such severe neonatal encephalopathy that they did not survive their second year.
|
11180222 |
2000 |